Literature DB >> 3328320

Different prevalence of thromboembolism in the subtypes of congenital antithrombin III deficiency: review of 404 cases.

G Finazzi, R Caccia, T Barbui.   

Abstract

Entities:  

Mesh：

Year:  1987        PMID： 3328320

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  14 in total

Review 1.  Inherited thrombophilia: memorandum from a joint WHO/International Society on Thrombosis and Haemostasis meeting.

Authors: 
Journal:  Bull World Health Organ       Date:  1997       Impact factor: 9.408

2.  Pleiotropic effects of antithrombin strand 1C substitution mutations.

Authors:  D A Lane; R J Olds; J Conard; M Boisclair; S C Bock; M Hultin; U Abildgaard; H Ireland; E Thompson; G Sas
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

Review 3.  Inherited risk factors for venous thromboembolism.

Authors:  Ida Martinelli; Valerio De Stefano; Pier M Mannucci
Journal:  Nat Rev Cardiol       Date:  2014-01-14       Impact factor: 32.419

Review 4.  Thrombophilia: how far should a clotter be investigated?

Authors:  I D Walker
Journal:  Postgrad Med J       Date:  1994-06       Impact factor: 2.401

5.  Usefulness of antithrombin deficiency phenotypes for risk assessment of venous thromboembolism: type I deficiency as a strong risk factor for venous thromboembolism.

Authors:  Mana Mitsuguro; Toshiyuki Sakata; Akira Okamoto; Sachika Kameda; Yoshihiro Kokubo; Yoshiaki Tsutsumi; Michitaka Sano; Toshiyuki Miyata
Journal:  Int J Hematol       Date:  2010-09-23       Impact factor: 2.490

Review 6.  Thrombophilia in pregnancy.

Authors:  I D Walker
Journal:  J Clin Pathol       Date:  2000-08       Impact factor: 3.411

Review 7.  Hereditary and acquired antithrombin deficiency: epidemiology, pathogenesis and treatment options.

Authors:  Peter S Maclean; R Campbell Tait
Journal:  Drugs       Date:  2007       Impact factor: 9.546

8.  Molecular characterization of antithrombin III (ATIII) variants using polymerase chain reaction. Identification of the ATIII Charleville as an Ala 384 Pro mutation.

Authors:  P Molho-Sabatier; M Aiach; I Gaillard; J N Fiessinger; A M Fischer; G Chadeuf; E Clauser
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

9.  Early Changes in the Antithrombin and Thrombin-Antithrombin Complex in Patients With Paroxysmal Atrial Fibrillation.

Authors:  Mariya Negreva; Svetoslav Georgiev; Krasimira Prodanova; Julia Nikolova
Journal:  Cardiol Res       Date:  2016-06-24

10.  Prevention and treatment of venous thromboembolism in pregnancy in patients with hereditary antithrombin deficiency.

Authors:  Andra H James; Barbara A Konkle; Kenneth A Bauer
Journal:  Int J Womens Health       Date:  2013-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.